Agios Pharmaceuticals presented new clinical data at ASH 2026 showing mitapivat provides durable hemoglobin improvements for up to two years in sickle cell disease patients, with additional kidney and heart benefits. The company also shared first human data for AG-236, supporting a potential every-six-month dosing for polycythemia vera. These findings highlight the potential of Agios' rare hematology treatments to transform care for patients with significant unmet needs. Agios will host a virtual investor event on December 14 to discuss these results further.
Agios Pharmaceuticals' new clinical data on mitapivat and AG-236 comes as 121 of 150 health-sector US stocks tradable on Pluang rose today. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 19:41 WIB: Novo Nordisk A/S (NVO) gained 5.92% to USD 42.57 with a typical hold time of 118 days and 90% buy order activity; HCA Health Inc (HCA) rose 5.86% to USD 490.00 with a 77-day hold time; Heron Therapeutics Inc (HRTX) increased 5.37% to USD 0.30 with a 38-day hold time and 66% buy order activity.
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
